Clinical trials
Phase 3 Basal Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 3 |
| Terminated | 2 |
| Recruiting | 1 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Galderma R&D | 4 |
| MEDA Pharma GmbH & Co. KG | 2 |
| Sol-Gel Technologies, Ltd. | 2 |
| Biofrontera Bioscience GmbH | 1 |
| Bispebjerg Hospital | 1 |
| Daryoush Hamidi Alamdari, PhD | 1 |
| Graceway Pharmaceuticals, LLC | 1 |
| QLT Inc. | 1 |
| Queen's Medical Center | 1 |
| Queen's University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Basal Cell Carcinoma | 22 |
| Carcinoma, Squamous Cell | 4 |
| Basal Cell Nevus Syndrome | 3 |
| Keratosis, Actinic | 2 |
| Bowen's Disease | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Merkel Cell | 1 |
| Carcinoma, Renal Cell | 1 |
| Carcinoma, Transitional Cell | 1 |
| Endometrial Neoplasms | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.